Purple
Phoenix™
The 30–120 day biological rebuild protocol. Designed for the post-surgical athlete in the phase where training is off the table and tissue repair is the only goal.
→ Recommended Phase: Immediately post-surgery through full tissue consolidation
Surgery is Day Zero.
Phoenix starts on Day One.
Think about the knee injury. The surgery happens. The surgeon closes the wound, the team helps you to the car, and the hardest part — the invisible part — begins. The biological rebuild.
The window immediately following surgery is the most critical and most undersupported phase of any athlete's recovery. Purple Phoenix™ was built specifically for these days — when the body needs coordinated biological signaling across every domain involved in tissue repair, not just rest and hope.
Once tissue is consolidated and the athlete returns to training — that's when Wolverine takes over.
One Coordinated
Signal.
Post-surgical tissue recovery doesn't happen in one system. It happens across every biological domain simultaneously. Purple Phoenix™ addresses all four — in coordination, not isolation.
Four Compounds.
One Rising.
BPC-157
Connective Tissue Signaling. Structural Recovery.
A gastric pentadecapeptide studied extensively for its interaction with tendon, ligament, muscle, and joint signaling pathways. Investigated in preclinical models for extracellular matrix communication and structural tissue adaptation under injury stress conditions.
↗ PubMed Research
TB-500
Cellular Migration. Angiogenic Remodeling.
A thymosin beta-4 fragment analog studied for cellular migration, actin regulation, and angiogenic signaling pathways. Research explores its involvement in wound-healing models and tissue remodeling mechanisms.
↗ PubMed Research
GHK-Cu
Collagen Signal. Structural Matrix Communication.
A naturally occurring copper-binding tripeptide widely studied for collagen expression, extracellular matrix organization, and connective tissue signaling. Investigated in research models for wound contraction and structural matrix remodeling.
↗ PubMed Research
KPV
Inflammatory Response. Barrier Signaling.
KPV, short for Lys-Pro-Val, is a tripeptide fragment derived from the C-terminal region of alpha-melanocyte-stimulating hormone. It is studied in laboratory and preclinical models for inflammatory-response signaling, immune pathway communication, epithelial integrity, mucosal barrier function, and cytokine-related pathway activity.
↗ PubMed ResearchBefore Returning to the Field
Choose Your
Path to Rise.
Two Paths.
One Rising.
Purple Phoenix™
Two Kits · Full 60-Day KPV Rebuild
Purple Phoenix™
Single Kit · 30-Day KPV Start
This Protocol Is.
This Protocol Is Not.
What Happens
Week by Week.
The First Signal
BPC-157 begins initiating connective-tissue signaling pathways. TB-500 starts engaging cellular migration mechanisms. GHK-Cu starts interacting with collagen and matrix signaling. KPV 10mg is positioned around inflammatory-response and epithelial-barrier signaling research. The rebuild is invisible on Day 1 — but the biological signal has begun.
Coordinated Repair
All four biological domains are active simultaneously. Cellular remodeling pathways are fully engaged. Inflammatory-response and epithelial-barrier signaling are being observed alongside collagen and structural communication pathways. This is the critical two-week window where protocol consistency defines rebuild quality.
Structural Consolidation
Four to eight weeks of coordinated biological signaling across every domain simultaneously. Structural, cellular, collagen, and inflammatory-response systems are operating in synchrony. Tissue reorganizes at a structural level. The foundation for Phase II is set.
Wolverine Phase Begins
Tissue consolidation complete. Return to training, gym, and field. Phase II — the Wolverine Protocol — takes over. Performance-phase biological support for the athlete back under load. The rebuild is done. The rise begins.
